{"paper_id":"debe2ddb-06d0-4f61-9a32-827310574556","body_text":"ENDOMETRIOSIS AND VTE: A REVIEW OF THE EVIDENCE AND PATHOPHYSIOLOGICAL MECHANISMS\nDOI:\nhttps://doi.org/10.31435/ijitss.3(47).2025.3489Keywords:\nDeep Vein Thrombosis, Endometriosis, Venous ThromboembolismAbstract\nIntroduction and objective: Endometriosis is a chronic inflammatory condition affecting approximately 10% of women of reproductive age. Venous thromboembolism (VTE) is a major cause of mortality worldwide. Because the relationship between endometriosis and VTE is not well-defined, we conducted a review of studies that assessed the occurrence of VTE in women with endometriosis.\nReview methods: A structured PubMed search was conducted to identify studies published between January 2015 and April 2025 assessing the risk of VTE in patients with endometriosis. Seven studies met the inclusion criteria after screening for relevance and exclusion of case reports.\nAbbreviated description of the state of knowledge: Some large-scale studies suggest an elevated VTE risk in women with endometriosis, particularly in younger individuals, during pregnancy, or when using hormonal therapy. However, results vary due to differences in study design, diagnostic definitions, and confounder adjustment. Pathophysiologically, endometriosis-related inflammation, hormonal influences, and endothelial dysfunction may contribute to a prothrombotic state.\nSummary: The association between endometriosis and VTE remains unclear; biologically plausible mechanisms and clinical patterns suggest it may be relevant in certain populations. Future research should focus on well-characterized, prospective studies. Clinicians should remain alert to thrombotic risk in women with endometriosis, especially when additional risk factors are present.\nReferences\nGiudice, L. C., & Kao, L. C. (2004). Endometriosis. Lancet (London, England), 364(9447), 1789–1799. https://doi.org/10.1016/S0140-6736(04)17403-5\nShafrir, A. L., Farland, L. V., Shah, D. K., Harris, H. R., Kvaskoff, M., Zondervan, K., & Missmer, S. A. (2018). Risk for and consequences of endometriosis: A critical epidemiologic review. Best practice & research. Clinical obstetrics & gynaecology, 51, 1–15. https://doi.org/10.1016/j.bpobgyn.2018.06.001\nSinaii, N., Plumb, K., Cotton, L., Lambert, A., Kennedy, S., Zondervan, K., & Stratton, P. (2008). Differences in characteristics among 1,000 women with endometriosis based on extent of disease. Fertility and sterility, 89(3), 538–545. https://doi.org/10.1016/j.fertnstert.2007.03.069\nTaylor, H. S., Kotlyar, A. M., & Flores, V. A. (2021). Endometriosis is a chronic systemic disease: clinical challenges and novel innovations. Lancet (London, England), 397(10276), 839–852. https://doi.org/10.1016/S0140-6736(21)00389-5\nNaess, I. A., Christiansen, S. C., Romundstad, P., Cannegieter, S. C., Rosendaal, F. R., & Hammerstrøm, J. (2007). Incidence and mortality of venous thrombosis: a population-based study. Journal of thrombosis and haemostasis : JTH, 5(4), 692–699. https://doi.org/10.1111/j.1538-7836.2007.02450.x\nBrækkan, S. K., & Hansen, J.-B. (2023). VTE epidemiology and challenges for VTE prevention at the population level. Thrombosis Update, 10, Article 100132. https://doi.org/10.1016/j.tru.2023.100132\nWaheed, S. M., Kudaravalli, P., & Hotwagner, D. T. (2023). Deep vein thrombosis. StatPearls Publishing.\nKumar, D. R., Hanlin, E., Glurich, I., Mazza, J. J., & Yale, S. H. (2010). Virchow's contribution to the understanding of thrombosis and cellular biology. Clinical medicine & research, 8(3-4), 168–172. https://doi.org/10.3121/cmr.2009.866\nZhang, W., Liu, X., Cheng, H., Yang, Z., & Zhang, G. (2018). Risk factors and treatment of venous thromboembolism in perioperative patients with ovarian cancer in China. Medicine, 97(31), e11754. https://doi.org/10.1097/MD.0000000000011754\nMammen E. F. (1992). Pathogenesis of venous thrombosis. Chest, 102(6 Suppl), 640S–644S. https://doi.org/10.1378/chest.102.6_supplement.640s\nLi, N., Huang, J., Feng, Y., Yan, H., Min, S., & Chen, X. (2024). Association Between Systemic Immune Inflammation Indexes and DVT in Patients With Malignancy Requiring PICC Insertion. Biological research for nursing, 26(4), 518–525. https://doi.org/10.1177/10998004241252468\nBeckman, M. G., Hooper, W. C., Critchley, S. E., & Ortel, T. L. (2010). Venous thromboembolism: a public health concern. American journal of preventive medicine, 38(4 Suppl), S495–S501. https://doi.org/10.1016/j.amepre.2009.12.017\nDe Corte, P., Milhoranca, I., Mechsner, S., Oberg, A. S., Kurth, T., & Heinemann, K. (2025). Unravelling the Causal Relationship between Endometriosis and the Risk for Developing Venous Thromboembolism: A Pooled Analysis. Thrombosis and haemostasis, 125(4), 385–394. https://doi.org/10.1055/a-2407-9498\nNassiri Kigloo, H., Mai, V., Suarthana, E., Tulandi, T., & Provencher, S. (2025). Polycystic Ovary Syndrome, Endometriosis, and Venous Thromboembolism: A Population-Based Study. Gynecologic and obstetric investigation, 1–8. Advance online publication. https://doi.org/10.1159/000545518\nEpelboin, S., Labrosse, J., Fauque, P., Levy, R., Gervoise-Boyer, M. J., Devaux, A., Bergère, M., de Vienne, C., Jonveaux, P., De Mouzon, J., & Pessione, F. (2021). Endometriosis and assisted reproductive techniques independently related to mother-child morbidities: a French longitudinal national study. Reproductive biomedicine online, 42(3), 627–633. https://doi.org/10.1016/j.rbmo.2020.11.017\nSugiura-Ogasawara, M., Ebara, T., Matsuki, T., Yamada, Y., Omori, T., Matsumoto, Y., Kato, S., Kano, H., Kurihara, T., Saitoh, S., Kamijima, M., & the Japan Environment & Children's Study (JECS) Group (2019). Endometriosis and Recurrent Pregnancy Loss as New Risk Factors for Venous Thromboembolism during Pregnancy and Post-Partum: The JECS Birth Cohort. Thrombosis and haemostasis, 119(4), 606–617. https://doi.org/10.1055/s-0039-1677733\nStewart, K. A., Tessier, K. M., & Lebovic, D. I. (2022). Comparing Characteristics of and Postoperative Morbidity after Hysterectomy for Endometriosis versus other Benign Indications: A NSQIP Study. Journal of minimally invasive gynecology, 29(7), 884–890.e2. https://doi.org/10.1016/j.jmig.2022.04.009\nMottais-Cosnefroy, V., Pecourt, M., Yannoutsos, A., Fels, A., Beaussier, H., Alran, S., Priollet, P., & Hugon-Rodin, J. (2022). Hormone-dependent gynaecological disorders and contraceptive modalities in women with a history of venous thromboembolic event: The THROMBOGYN study. Journal de medecine vasculaire.., 47(5-6), 228–237. https://doi.org/10.1016/j.jdmv.2022.10.015\nWiegers, H. M. G., Scheres, L. J. J., Tahir, L., Hutten, B. A., Middeldorp, S., & Mijatovic, V. (2022). Risk of venous thromboembolism in women with endometriosis. Thrombosis research, 217, 104–106. https://doi.org/10.1016/j.thromres.2022.07.014\nLidegaard, Ø., Løkkegaard, E., Svendsen, A. L., & Agger, C. (2009). Hormonal contraception and risk of venous thromboembolism: national follow-up study. BMJ (Clinical research ed.), 339, b2890. https://doi.org/10.1136/bmj.b2890\nvan Hylckama Vlieg, A., Helmerhorst, F. M., Vandenbroucke, J. P., Doggen, C. J., & Rosendaal, F. R. (2009). The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study. BMJ (Clinical research ed.), 339, b2921. https://doi.org/10.1136/bmj.b2921\nLidegaard, O., Nielsen, L. H., Skovlund, C. W., & Løkkegaard, E. (2012). Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10. BMJ (Clinical research ed.), 344, e2990. https://doi.org/10.1136/bmj.e2990\nDunselman, G. A., Vermeulen, N., Becker, C., Calhaz-Jorge, C., D'Hooghe, T., De Bie, B., Heikinheimo, O., Horne, A. W., Kiesel, L., Nap, A., Prentice, A., Saridogan, E., Soriano, D., Nelen, W., & European Society of Human Reproduction and Embryology (2014). ESHRE guideline: management of women with endometriosis. Human reproduction (Oxford, England), 29(3), 400–412. https://doi.org/10.1093/humrep/det457\nMeknas, D., Brækkan, S. K., Hansen, J. B., & Morelli, V. M. (2023). Surgery As a Trigger for Incident Venous Thromboembolism: Results from a Population-Based Case-Crossover Study. TH open : companion journal to thrombosis and haemostasis, 7(3), e244–e250. https://doi.org/10.1055/a-2159-9957\nSmeets, M. J. R., Touw, C. E., Rosendaal, F. R., Nemeth, B., & Cannegieter, S. C. (2023). The risk of venous thromboembolism after minor surgical procedures: A population-based case-control study. Journal of thrombosis and haemostasis : JTH, 21(4), 975–982. https://doi.org/10.1016/j.jtha.2022.11.035\nEsmon C. T. (2003). Inflammation and thrombosis. Journal of thrombosis and haemostasis : JTH, 1(7), 1343–1348. https://doi.org/10.1046/j.1538-7836.2003.00261.x\nRana, N., Braun, D. P., House, R., Gebel, H., Rotman, C., & Dmowski, W. P. (1996). Basal and stimulated secretion of cytokines by peritoneal macrophages in women with endometriosis. Fertility and sterility, 65(5), 925–930.\nPircher, J., Merkle, M., Wörnle, M., Ribeiro, A., Czermak, T., Stampnik, Y., Mannell, H., Niemeyer, M., Vielhauer, V., & Krötz, F. (2012). Prothrombotic effects of tumor necrosis factor alpha in vivo are amplified by the absence of TNF-alpha receptor subtype 1 and require TNF-alpha receptor subtype 2. Arthritis research & therapy, 14(5), R225. https://doi.org/10.1186/ar4064\nvan Aken, B. E., Reitsma, P. H., & Rosendaal, F. R. (2002). Interleukin 8 and venous thrombosis: Evidence for a role of inflammation in thrombosis. British Journal of Haematology, 116(1), 173–177. https://doi.org/10.1046/j.1365-2141.2002.03245.x\nMay, K. E., Conduit-Hulbert, S. A., Villar, J., Kirtley, S., Kennedy, S. H., & Becker, C. M. (2010). Peripheral biomarkers of endometriosis: a systematic review. Human reproduction update, 16(6), 651–674. https://doi.org/10.1093/humupd/dmq009\nNisenblat, V., Prentice, L., Bossuyt, P. M., Farquhar, C., Hull, M. L., & Johnson, N. (2016). Combination of the non-invasive tests for the diagnosis of endometriosis. The Cochrane database of systematic reviews, 7(7), CD012281. https://doi.org/10.1002/14651858.CD012281\nSmyk, J. M., Danielecka, Z., Kotowska, M., Zawadka, M., Andruszkiewicz, P., Grąt, M., Główczyńska, R., Grabowski, M., Gąsecka, A., & Romejko‑Wolniewicz, E. (2024). Cardiovascular risks and endothelial dysfunction in reproductive‑age women with endometriosis. Scientific Reports, 14(1), Article 24127. https://doi.org/10.1038/s41598-024-73841-7\nViganò, P., Ottolina, J., Sarais, V., Rebonato, G., Somigliana, E., & Candiani, M. (2018). Coagulation Status in Women With Endometriosis. Reproductive sciences (Thousand Oaks, Calif.), 25(4), 559–565. https://doi.org/10.1177/1933719117718273\nOttolina, J., Bartiromo, L., Dolci, C., Salmeri, N., Schimberni, M., Villanacci, R., Viganò, P., & Candiani, M. (2020). Assessment of Coagulation Parameters in Women Affected by Endometriosis: Validation Study and Systematic Review of the Literature. Diagnostics (Basel, Switzerland), 10(8), 567. https://doi.org/10.3390/diagnostics10080567\nDownloads\nPublished\nIssue\nSection\nLicense\nAll articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.\nCC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.","source_license":"CC0","license_restricted":false}